Dianthus Therapeutics Inc
DNTHHealthcare|Biotechnology|USA
$97.54
-2.41 (-2.41%)
Tangible Book
$22.01
Clinical Trials (5)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06858579 A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) | Chronic Inflammatory Demyelinating Polyneuropathy | P3 | Recruiting | 256 | RCT, Double-blind | Claseprubart, Claseprubart, Placebo |
| NCT07647510 A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) | Myasthenia Gravis, Generalized | P3 | Recruiting | 195 | RCT, Double-blind | Claseprubart, Placebo |
| NCT06282159 A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) | Myasthenia Gravis, Generalized | P2 | Active | 65 | RCT, Double-blind | Claseprubart, Placebo |
| NCT06537999 A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy | Multifocal Motor Neuropathy | P2 | Recruiting | 36 | RCT, Double-blind | Claseprubart, Placebo |
| NCT05800509 Gestational Diabetes and Perinatal Depression: an Intervention Program | Gestational Diabetes Mellitus, Postpartum Depression | N/A | Recruiting | 600 | RCT, Single-blind | — |